Dupilumab (Dupixent) by Sanofi has initially been marketed for the treatment of uncontrolled moderate-to-severe Atopic Dermatitis. Its indications have since…
In conjunction with Institut Kanser Negara’s (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.
The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.
Recent data from the Jakarta Health Agency revealed an uptick in Acute Respiratory Infections (ISPA) post-pandemic cases. The agency reported approximately 146,000 ISPA cases monthly this year. Interestingly, while this is higher than the pandemic period, it’s still consistent with the numbers from 2018 and 2019.
A 28-year-old Singaporean, Darrel Phee, lost his life while attempting to climb Mount Kilimanjaro. His tragic death sheds light on the potential dangers of high-altitude climbing, even when safety measures are in place.
The new coronavirus Omicron subvariant EG.5.1, detected in Thailand, Singapore, and Indonesia, has prompted vigilance but not panic across Asian health communities.
Seasonal flu, also known as influenza, is a recurrent global health concern. It’s a viral infection, primarily attacking the respiratory system. Symptoms can range from mild to severe, with complications like pneumonia being potentially fatal.
In an unprecedented move, Moderna, a biotech firm based in Massachusetts, USA, has struck a landmark deal with Chinese officials to research, develop and manufacture messenger RNA (mRNA) medicines in China.
